Month: April 2021

Please find enclosed the 2020 Annual Report for AKVA group ASA and AKVA group.The Annual Report is also published onhttps://ir.akvagroup.com/investor-relations/financial-information/annual-reports. AKVA group’s report on Corporate Governance and Corporate Social Responsibility can be found in separate sections of the Annual Report for 2020. As stated in our Q4 report the income tax in the P&L was based on estimates. In the annual report the income tax is finally calculated. In addition, there was a change in currency gains included in net financial items. In total this resulted in net profit being NOK 4 million higher in the Annual Report 2020 compared to the Q4 report. Dated: 14 April 2021AKVA group ASA Web: www.akvagroup.com CONTACTS:Knut Nesse Chief Executive OfficerPhone: +47 51 77 85 00Mobile: +47 91 37 62 20E-mail: knesse@akvagroup.comRonny...

Bedminster, NJ, April 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) is proud to announce the recent opening of its Boonton, NJ branch.  Located at 104 Ely Place, the Bank’s newest retail location, and its 20th overall, will serve the communities of Boonton, Boonton Township, Mountain Lakes and the surrounding areas. The full-service branch offers personal and business banking solutions, as well as wealth management, investment banking, professional services and consumer and commercial lending.   The branch is now open Monday through Friday from 9:00 am to 5:00 pm, with a late night on Thursday until 6:00 pm and Saturday hours from 9:00 am to 12:00 noon.  Fully operational drive-up services, a 24-hour ATM, safe deposit boxes and night deposit services...

DULLES, Va., April 14, 2021 (GLOBE NEWSWIRE) — The National Rural Utilities Cooperative Finance Corporation (CFC) will hold an investor conference call and webcast on Friday, April 16, at 1 p.m. Eastern Time. CFC Senior Vice President and CFO Andrew Don will review CFC’s fiscal year 2021 third-quarter financial results. There are two ways to access the event:Conference Call OptionDomestic: 800-367-2403 | International: 334-777-6978Participant Code: 4419441Callers also can view a PDF of the slide presentation by visiting the Webcasts & Presentations page on the day of the call. It will be posted just prior to the broadcast.A replay of the webcast will be available on the Webcasts & Presentations page after the event. CFC’s Form 10-Q for the period ended February 28, 2021, has been filed with the U.S. Securities and...

Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) — The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular heartbeats BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the release of the PURE EP™ Software Version 4. The latest release builds on the main system capabilities of the PURE EPTM while improving the overall user experience. The software upgrade will be rolled out to all new and existing customers. The latest software represents the most advanced software version of the PURE EPTM System. The update adds valuable tools...

JASPER, Ind., April 14, 2021 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) will announce its third quarter fiscal year 2021 financial results on Tuesday, May 4, 2021, after the close of the market.   The Company will host a conference call on Tuesday, May 4, 2021, at 5:00 p.m. ET to review its financial performance. The telephone number to access the conference call is 844-602-5643 or internationally at 574-990-3014. The passcode to access the call is “Kimball.” The live webcast of the conference call can be accessed at www.ir.kimballinternational.com. For those unable to participate in the live webcast, the call will be archived at www.ir.kimballinternational.com. About Kimball International, Inc. Kimball International is a leading omnichannel commercial furnishings company. For over 70 years, we have...

LOGANSPORT, Ind., April 14, 2021 (GLOBE NEWSWIRE) — Logansport Financial Corp., (OTCBB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended March 31, 2021 of $934,000 or $1.52 per diluted share, compared to earnings in 2020 of $613,000 or $1.00 per diluted share. The Dividends paid to shareholders were $0.40 per share in the first quarter of 2021. Total loans were $137.7 million on March 31, 2021 compared to $135.0 million on December 31, 2020. Deposits were $213.0 million on March 31, 2021 compared to $189.5 million on December 31, 2020. Total assets on March 31, 2021 were $243.0 million compared to $220.4 million on December 31, 2020. Total Shareholders’ Equity on March 31, 2021 was $28.5 million compared to $25.1 million on March 31, 2020. The statements contained in this press release...

April 14, 2021; Oslo, Norway, reference is made to PGS ASA (the “Company”) convertible bond loan with ISIN NO0010920697 in the aggregate amount of NOK 116,162,097 issued in Q1 2021. The Company has received conversion notices from convertible bondholders representing NOK 8 424 249 in this bond issue to convert 8 424 249 bonds into shares with a conversion price of NOK 3. Pursuant to standard terms set out in the bond terms, the bonds are thus convertible into 2,808,083 new freely tradable shares in the Company. After the conversion, the remaining principal outstanding under the convertible bond loan amounts to NOK 95 116 698. The share capital increase pertaining to the conversion of convertible bonds has today been registered in the Norwegian Register of Business Enterprises (Nw.:Foretaksregisteret). The Company’s new share capital...

Marts 2021 Sales price Group sales prices development as followsQ1           2017       1,24 EUR/kg live weight (Jan 1,23 EUR – Feb 1,24 EUR – Marts 1,26 EUR) Q2           2017       1,41 EUR/kg live weight (Apr 1,43 EUR – May 1,41 EUR – June 1,39 EUR) Q3           2017       1,30 EUR/kg live weight (July 1,32 EUR – Aug 1,30 EUR – Sept 1,29 EUR) Q4           2017       1,13 EUR/kg live weight (Oct 1,17 EUR – Nov 1,12 EUR – Dec 1,11 EUR) Q1           2018       1,09 EUR/kg live weight (Jan 1,07 EUR – Feb 1,08 EUR – Marts 1,12 EUR) Q2           2018       1,17 EUR/kg live weight (April 1,18 EUR – May 1,15 EUR – June 1,18 EUR) Q3           2018       1,19 EUR/kg live weight (July 1,19 EUR, August 1,18 EUR, September 1,19) Q4           2018       1,10 EUR/kg live weight (Oct 1,11 EUR – Nov 1,12 EUR – Dec 1,07 EUR) Q1           2019      ...

Not for Distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO & NVO.WT; OTCQX: NSRPF) has appointed Clarus Securities Inc. and Stifel GMP as co-lead agents on behalf of a syndicate of agents, to raise, by way of a marketed private placement, C$22 million ‎(or up to C$26.4 million if the Agents’ Option (as defined below) is exercised in full) (the “Offering”). Pursuant to the proposed Offering, the Company will issue special warrants (“Special Warrants“) of the Company at a price of C$2.55 per Special Warrant. Each Special Warrant will be convertible into one unit of the Company (each, a “Unit“) without payment of any additional consideration....

LEXINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced the dosing of the first cancer patient with agenT-797, an allogeneic iNKT cell therapy, in a Phase 1 clinical trial through its subsidiary, AgenTus Therapeutics. “Our proprietary iNKT cell therapy has been advancing in the clinic in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19; we are now expanding our iNKT cell therapy to treat patients with cancer,” said Jennifer Buell, PhD, President and COO of Agenus. “iNKT cells penetrate tissues, demonstrate potent tumor killing, and show compelling curative potential in solid...